| Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance AB Nagaraj, P Joseph, O Kovalenko, S Singh, A Armstrong, R Redline, ... Oncotarget 6 (27), 23720, 2015 | 213 | 2015 |
| CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors C Saygin, A Wiechert, VS Rao, R Alluri, E Connor, PS Thiagarajan, ... Journal of Experimental Medicine 214 (9), 2715-2732, 2017 | 85 | 2017 |
| Altered glutamine metabolism in platinum resistant ovarian cancer CD Hudson, A Savadelis, AB Nagaraj, P Joseph, S Avril, A DiFeo, N Avril Oncotarget 7 (27), 41637, 2016 | 83 | 2016 |
| Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment AB Nagaraj, QQ Wang, P Joseph, C Zheng, Y Chen, O Kovalenko, ... Oncogene 37 (3), 403-414, 2018 | 82 | 2018 |
| Cisplatin induces stemness in ovarian cancer A Wiechert, C Saygin, PS Thiagarajan, VS Rao, JS Hale, N Gupta, ... Oncotarget 7 (21), 30511, 2016 | 68 | 2016 |
| Functional characterization of 84 PALB2 variants of uncertain significance T Wiltshire, M Ducy, TK Foo, C Hu, KY Lee, AB Nagaraj, A Rodrigue, ... Genetics in Medicine 22 (3), 622-632, 2020 | 43 | 2020 |
| miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer AB Nagaraj, P Joseph, A DiFeo Biomarkers in medicine 9 (3), 241-257, 2015 | 29 | 2015 |
| The miR–181a–SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer A Belur Nagaraj, M Knarr, S Sekhar, RS Connor, P Joseph, O Kovalenko, ... Cancer research 81 (8), 2044-2055, 2021 | 26 | 2021 |
| InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer N Dimitrova, AB Nagaraj, A Razi, S Singh, S Kamalakaran, N Banerjee, ... Oncogene 36 (17), 2472-2482, 2017 | 24 | 2017 |
| miR-181a modulates circadian rhythm in immortalized bone marrow and adipose derived stromal cells and promotes differentiation through the regulation of PER3 M Knarr, AB Nagaraj, LJ Kwiatkowski, A DiFeo Scientific Reports 9 (1), 307, 2019 | 20 | 2019 |
| Mitotic exit dysfunction through the deregulation of APC/C characterizes cisplatin-resistant state in epithelial ovarian cancer A Belur Nagaraj, O Kovalenko, R Avelar, P Joseph, A Brown, A Surti, ... Clinical Cancer Research 24 (18), 4588-4601, 2018 | 18 | 2018 |
| A miRNA-mediated approach to dissect the complexity of tumor-initiating cell function and identify miRNA-targeting drugs AB Nagaraj, P Joseph, E Ponting, Y Fedorov, S Singh, A Cole, W Lee, ... Stem Cell Reports 12 (1), 122-134, 2019 | 10 | 2019 |
| Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer AB Nagaraj, P Joseph, O Kovalenko, QQ Wang, R Xu, A DiFeo Gynecologic oncology 151 (3), 525-532, 2018 | 9 | 2018 |
| Functional and clinical characterization of variants of uncertain significance identifies a hotspot for inactivating missense variants in RAD51C C Hu, AB Nagaraj, H Shimelis, G Montalban, KY Lee, H Huang, ... Cancer research 83 (15), 2557-2571, 2023 | 2 | 2023 |
| Host and tumor factor XII drive ovarian cancer maintenance and progression EX Stavrou, KL Bane, P Joseph, AB Nagaraj, A Difeo Blood 134, 2384, 2019 | 2 | 2019 |
| The wnt/β-catenin-specific inhibitor, ICG-001, proves effective for the treatment of high-grade serous ovarian cancer in murine models through the targeting of cancer … RS Connor, AB Nagaraj, P Joseph, S Mantilla, O Kovalenko, CI Nagel, ... Gynecologic Oncology 145, 120-121, 2017 | 1 | 2017 |
| miR-181a is a key driver of genomic instability and ovarian cancer tumorigenesis through the regulation of RB1 M Knarr, L Kwiatkowski, A Nagaraj, R Drapkin, A DiFeo Cancer Research 79 (13_Supplement), 3557-3557, 2019 | | 2019 |
| miRNA 3'UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity. AB Nagaraj, P Joseph, M Knarr, O Kovalenko, A Surti, A Difeo CLINICAL CANCER RESEARCH 24 (15), 118-119, 2018 | | 2018 |
| Abstract B66: miRNA 3’UTR activity driven enrichment of ovarian tumor-initiating cells (TICs) to overcome the barriers of heterogeneity and TIC plasticity AB Nagaraj, P Joseph, M Knarr, O Kovalenko, A Surti, A DiFeo Clinical Cancer Research 24 (15_Supplement), B66-B66, 2018 | | 2018 |
| 4: 03 PM Abstract No. 259 Utility of metal artifact reduction to improve visualization of therapeutic ice ball in CT-guided cryoablation of musculoskeletal metastases A Nagaraj, E Lin, G Chintalapani, JR Giraldo, R Sheth, A Tam, S Yevich Journal of Vascular and Interventional Radiology 29 (4), S111-S112, 2018 | | 2018 |
